Why Arizona Men 40 to 70 Delay Prostate Care — And Why New Options Like Focal One HIFU Are Changing That

Arizona prostate care

Share This Post

For many men in Arizona, especially between ages 40 and 70, the biggest barrier to better health is not a lack of options. It is waiting too long to act. Men continue to use preventive care less often than women, and recent reporting citing national health data shows men are roughly one-third less likely than women to have seen a doctor in the past year. When the concern involves urinary symptoms, sexual health, or possible prostate cancer, avoidance often becomes even more common because fear, embarrassment, and the urge to “wait and see” can outweigh common sense.

That delay matters. For prostate cancer, five-year relative survival is about 100% when the disease is found at a localized stage, but falls sharply for distant-stage disease. For men in the Greater Phoenix area, that makes early evaluation more than a routine checkup. It is the step that preserves the widest range of treatment choices, including minimally invasive Focal One robotic High-Intensity Focused Ultrasound (HIFU) that were not available to many patients a few years ago.

Why men 40 to 70 often put it off

Men in the 40 to 70 age range are often balancing work, family responsibilities, aging parents, finances, and the physical changes that come with midlife and later adulthood. In this stage of life, many men normalize getting up at night to urinate, a weaker urinary stream, pelvic discomfort, erection changes, or fatigue, even when those symptoms deserve medical attention. Research on men’s healthcare use shows that avoidance is commonly tied to fear of diagnosis, reluctance to discuss intimate symptoms, distrust of the medical system, and cultural ideas that toughness means staying silent.

That pattern is especially risky with prostate disease. Prostate cancer is one of the most common cancers in men, and treatment decisions are often most flexible when cancer is found early and remains localized. Men who act early may have more opportunities to consider surveillance, focal treatment, or other organ-preserving strategies instead of confronting fewer choices after disease progression.

The cost of delayed prostate evaluation

A man who ignores persistent urinary symptoms or postpones PSA testing is not simply postponing a conversation. He may be delaying the imaging, biopsy review, and risk assessment that determine whether a prostate problem is benign enlargement, inflammation, or cancer. That distinction matters because localized prostate cancer has an excellent outlook, while metastatic disease is far harder to treat and carries much lower five-year survival.

This is also why language around “watchful waiting” can be misleading. The right approach is not passive avoidance; it is informed evaluation. Some men are appropriate for active surveillance, but that decision should come after expert review of PSA trends, MRI findings, biopsy pathology, age, health status, and treatment goals.

Why EVUC stands out in the East Valley

East Valley Urology Center (EVUC) positions itself as an advanced urology destination serving communities across Mesa, Queen Creek, Scottsdale, and Globe. The practice highlights expertise in prostate cancer care, minimally invasive surgery, men’s health, and focal therapies, with Dr. Rahul Mehan serving as founder and CEO.

Dr. Mehan is a board-certified urologist with experience spanning robotic surgery for kidney and prostate cancer, Focal One robotic High-Intensity Focused Ultrasound (HIFU) , NanoKnife, and TULSA-PRO, as well as broader men’s health services including hormone optimization and vasectomy. EVUC states that its HIFU program includes a multidisciplinary team involving urologists, medical oncologists, pathologists, radiologists, and clinical support staff to help guide treatment decisions for individual patients.

The center’s messaging is especially relevant for men who want expert care without feeling shuffled through a generic system. EVUC describes a prostate program designed around advanced technology, individualized planning, and access for patients in the Greater Phoenix region, including Mesa. For men ages 40 to 70, that combination can make it easier to move from avoidance to action because it reframes care as precise, modern, and focused on preserving quality of life.

Dr. Mehan and the expert urology team

Dr. Rahul Mehan is one of the leading innovators in Arizona urology, with national recognition for minimally invasive and robotic approaches. His profile notes involvement as a principal investigator in pivotal clinical trials for Aquablation and TULSA-PRO and reports that he has performed more than 600 Aquablation procedures, Focal One robotic High-Intensity Focused Ultrasound (HIFU) procedures,placing him among the highest-volume providers globally.

For prostate patients, that matters because experience and breadth of treatment options shape the quality of the conversation. A team that understands surgery, Focal One robotic High-Intensity Focused Ultrasound (HIFU) , imaging-driven planning, and men’s health can better match treatment to the patient instead of forcing every man into the same path. EVUC says the practice has grown to nine urologists across four offices, helping reinforce its image as one of the premier urology practices in the Southwest.

How Focal One Robotic HIFU changes the treatment conversation

Focal One robotic High-Intensity Focused Ultrasound (HIFU) is an advanced treatment platform that uses focused ultrasound energy to ablate targeted prostate tissue without incisions or radiation. Manufacturer and clinical descriptions of Focal One emphasize image guidance, MRI and ultrasound fusion, and submillimetric targeting intended to destroy the diseased portion of the prostate while sparing surrounding healthy tissue.

That precision is exactly why focal therapy has gained attention among men who are worried not only about cancer control, but also about urinary continence, sexual function, recovery time, and time away from work or normal life. Clinical and provider descriptions characterize HIFU as a minimally invasive option for select men with localized, early-stage prostate cancer, particularly when the cancer can be clearly identified on imaging and treatment can be directed at the affected area.

In practical terms, Focal One helps change the emotional calculus for men who fear that getting checked will automatically lead to radical surgery or radiation. For the right patient, focal HIFU can offer a middle path between active surveillance and whole-gland treatment. That is an important message for Arizona men in their forties, fifties, sixties, and seventies who may delay evaluation because they assume every diagnosis leads to the same life-disrupting outcome.

HonorHealth Four Peaks connection

EVUC highlights advanced prostate care in Mesa and the Greater Phoenix area, and this positioning aligns well with HonorHealth Four Peaks Medical Center in East Mesa. HonorHealth Four Peaks Medical Center is located at 1301 S. Crismon Road in Mesa and describes itself as a 178-bed hospital equipped with leading-edge medical technology, robotic surgical technology, inpatient and outpatient services, and broad specialty support.

For many Arizona families, access matters almost as much as technology. Studies show Men are more likely to follow through when care is local, the message is clear, and the next step feels manageable. Positioning EVUC and Dr. Mehan’s team alongside the premier East Mesa setting of HonorHealth Four Peaks helps remove one of the biggest barriers to action: uncertainty about where to go first.

Updated statistics to highlight in charts

Metric Updated figure Why it matters
Men vs. women seeing a doctor in the past year Men are about 33% less likely than women to have visited a doctor in the past year. Reinforces the core avoidance problem.
Adults with a doctor/health professional visit in the past year 85.2% of adults had a visit in 2024. Shows healthcare contact is common overall, making male avoidance stand out.
Prostate cancer 5-year survival, localized disease About 100%. Supports the value of early detection.
Prostate cancer 5-year survival, distant disease Roughly 28% to 38%, depending on source and reporting year. Shows the cost of waiting.

For men in Arizona ages 40 to 70, getting evaluated for prostate symptoms is no longer just about finding disease. It is about protecting choices. With expert urologists, advanced imaging, and focal options like Focal One robotic HIFU available through EVUC (East Valley Urology Center) and Dr. Rahul Mehan’s team in the Greater Phoenix area, men have more ways than ever to act early and stay in control of their health.

EVUC of Arizona promotes a different kind of prostate care experience: specialized urology, modern technology, and a team-based model designed to give men clear answers and individualized treatment planning close to home. The practice has grown to nine urologists across four offices serving Mesa, Queen Creek, Scottsdale, and Globe, reinforcing its position as a major urology destination in the East Valley and across Arizona.

And now EVUC paired with HonorHealth Four Peaks Medical Center in East Mesa. HonorHealth Four Peaks at 1301 S. Crismon Road,  they are better equipped with leading-edge medical technology and robotic surgical capabilities, EVUC is fast becoming the leader for advanced prostate care in Arizona.

To learn more contact them via www.evucenter.com

 

More To Explore